ArticleFrontiers in medicine2026
Few-shot annotation correction for lightweight retinal vessel image segmentation.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinal vessel segmentation underpins quantitative analysis in ophthalmology and is widely used for screening and diagnosis. In practice, manual annotations for thin and tortuous vessels are error-prone, yet the effect of positional label noise on segmentation quality remains underexplored. We address this gap with a lightweight few-shot U-Net-based framework for annotation correction and noise robust learning. Analyses on DRIVE reveal clear performance degradation as label displacement increases. Cross-dataset validation shows that the proposed method attains an Accuracy of 96.51, an AUC of 98.01, and an F1 of 83.55 on CHASE_DB1 and an Accuracy of 97.54, an AUC of 98.45, and an F1 of 83.11 on STARE, achieving competitive performance against state-of-the-art methods. These results quantify the sensitivity of vessel segmentation to positional annotation errors and demonstrate practical robustness under noisy labels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.